Glycaemic control and in vivo non-oxidative Maillard reaction: Urinary excretion of pyrraline in diabetes patients

European Journal of Clinical Investigation

Volumn 27, Issue 9, 1997, Pages 767-773

  Portero Otin M ^a   Pamplona, R ^a   Bellmunt, M J ^a   Bergua, M ^a   Prat, J ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Glycaemic control; HbA1(c); Maillard reaction; Pyrraline; Urine

Indexed keywords

HEMOGLOBIN A1C; INSULIN; PYRRALINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CONCENTRATING CAPACITY; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 0030796507     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1900740.x     Document Type: Article

References (38)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Brownlee M, Cerami A. The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem 1981;50:385-432.
3. Kahn CR, Weir G. Joslins's Diabetes. Philadelphia: Lea & Febiger, 1994.
4. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
5. Njoroge FG, Monnier VM. The chemistry of the Maillard reaction under physiological conditions: a review. Prog Clin Biol Res 1989; 304:85-107.
6. Dyer DG, Dunn JA, Thorpe SR et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463-69.
7. Ledl F, Schleicher E. New aspects of the Maillard reaction in foods and in the human body. Angew Chem Int Ed Engl 1990;29:565-94.
8. Fu, MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard Reaction. Diabetes 1994;43:676-83.
9. Dunn, JA, Patrick JS, Thorpe SR, Baynes JW. Oxidation of glycated proteins: age dependent accumulation of N- (carboxymethyl)lysine in lens proteins. Biochemistry 1990;28:9464-68.
10. Ahmed MU, Thorpe SR, Baynes JW. Identification of N-carboxymethyl-lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889-94.
11. Dyer, DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of protein by glucose: identification of glucose and other carbohydrates us possible precursors of pentosidine in vivo. J Biol Chem 1991;266:11654-60.
12. Sell DR, Monnier VM. Structure elucidation of a senescence crosslink from human extracellular matrix: implication of pentoses in the aging process. J Biol Chem 1989;264:21597-602.
13. Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein crosslink pentostidine: glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 1989;266:11649-53.
14. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM. Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 1989;264: 3758-64.
15. Njoroge FG, Sayre LM, Monnier VM: Detection of D-glucose derived pyrrole compound during Maillard reaction under physiological conditions. Carbohydr Res 1987;167:211-20.
16. Miyata S, Monnier VM. Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibodies to pyrraline. J Clin Invest 1992;89:1102-12.
17. Portero-Otin M, Nagaraj RH, Monnier VM. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim Biophys Acta 1995;1247:74-80.
18. Nagaraj RH, Sady C. The presence of a glucose-derived Maillard reaction product in the human lens. FEBS Lett 1996;382:234-38.
19. Portero M, Pamplona R, Bellmunt MJ, Nagaraj RH, Monnier VM, Prat J. Ageing of proteins: urinary excretion for pyrraline formed during Maillard reaction in vivo. J Physiol 1996; 493P: 60S.
20. Odani H, Shinzato T, Matsumoto Y et al. First evidence for accumulation of protein bound and protein free pyrraline in human uremic plasma. Biochem Biophys Res Commun 1996;224:237-41.
21. Takahashi M, Ohishi T, Aoshima H et al. The Maillard protein crosslink pentosidine in urine from diabetic patients. Diabetologia 1993;36:664-7.
22. Knecht KJ, Dunn J, McFarland KF et al. Effect of diabetes and ageing on carboxymethyllysine levels in human urine. Diabetes 1991;40:190-6.
23. John WG, Edwards R, Price CP. Laboratory evaluation of the DCA 2000 Clinic HbAlc immunoassay analyser. Ann Clin Biochem 1994;31:367-70.
24. Schleicher, E, Mayer, R. Wagner, EM, Gergitz KD. Is serum fructosamine assay specific for determination of glycated serum protein? Clin Chem 1988;34:320-3.
25. Fisken, RA, Chan AW, Hanlon A, MacFarlane IA. Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in young adults with insulin-dependent diabetes. Clin Chim Acta 1990;191:79-86.
26. Davies SJ, Whiting KL, Gould BJ. Biological variation in glycated proteins. Ann Clin Biochem 1993;30:260-4.
27. Fluckiger R, Woodtli T, Berger W. Evaluation of the fructosamine test for the measurement of plasma protein glycation. Diabetologia 1987;30:648-52.
28. McCance DR, Coulter D, Smye M, Kennedy L. Effect of fluctuations in albumin on serum fructosamine assay. Diabet Med 1987;4:434-6.
29. Knecht KJ, Feather MS, Baynes JW. Detection of 3-deoxyfructose and 3deoxyglucosone in human urine and plasma: Evidence for intermediates stages of the Maillard reaction in vivo. Arch Biochem Biophys 1992;294:130-7.
30. Yamada H, Miyata S, Iigaki N et al. Increase in 3-deoxyglucosone levels in diabetic rat plasma. J Biol Chem 1994;269:20275-80.
31. Wells-Knecht KJ, Lyons TJ, McCance DR, Thorpe SR, Feather MS, Baynes JW. 3-deoxyfructose concentrations are increased in human plasma and urine in diabetes. Diabetes 1994;43:1152-6.
32. Brownlee M. Glycation and diabetic complications. Diabetes 1994;43:836-41.
33. Porte D, Schwartz MW. Diabetes complications: Why is glucose potentially toxic. Science 1996;272:699-700.
34. Nagaraj RH, Portero-Otin M, Monnier VM. Pyrraline ether crosslinks as a basis for protein crosslinking by advanced Maillard reaction in aging and diabetes. Arch Biochem Biophys 1996;325: 152-8.
35. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycaemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 1991; 87: 1910-15.
36. Nagaraj RH, Kern TS, Sell DR, Fogarty J, Engerman RL, Monnier VM. Evidence of a glycaemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes 1996;45: 587-94.
37. Salmela PI, Oikarinen AI, Ukkola O et al. Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen. Eur J Clin Invest 1995;25:494-500.
38. Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 1996;346:513-15.